(Reuters) – GW Pharmaceuticals Plc’s cannabis-derived drug to treat a severe form of childhood epilepsy was unanimously backed on Thursday by an advisory panel to the U.S. Food and Drug Administration.
Source: Reuters Medical News
(Reuters Health) – A new study of hundreds of thousands of U.S. armed forces veterans concludes that banging your head severely enough to lose consciousness can dramatically increase the risk of Parkinson’s, the brain disease marked by tremors, slow movements, balance problems and difficulty walking.
Source: Reuters Medical News
(Reuters) – An experimental rheumatoid arthritis drug developed by Eli Lilly and Co and Incyte Corp poses serious risks of deadly blood clots at higher doses, U.S. Food and Drug Administration staff said on Thursday, the latest setback to a treatment regulators declined to approve last year.
Source: Reuters Medical News
Should be recommended along with other lifestyle advice, say researchers
Related items from OnMedica Atrial fibrillation risk lower with regular nut consumption |
Source: OnMedica
Eight standards cover range of care from diagnosis to end of life
Related items from OnMedica HIV life expectancy ‘near normal’ due to antiretroviral therapy |
Source: OnMedica
They don’t get the right treatment and often suffer needless disability and early death
Related items from OnMedica GMC calls for major overhaul of medical training |
Source: OnMedica
BMA and royal colleges call for immediate changes to be made to youth justice system
Related items from OnMedica Mental health needs better management in criminal justice system |
Source: OnMedica
System can boost normal blood glucose time by almost 2.5 hours
Related items from OnMedica Continuous glucose monitoring beneficial in type 1 diabetes |
Source: OnMedica